Surgery therapy for polypoidal choroidal vasculopathy

Authors: Jiao Mingfei,  Li Xiaorong,  Hu Bojie

DOI: 10.3760/cma.j.cn115985-20200519-00354
Published 2020-07-10
Cite as Chin J Exp Ophthalmol, 2020,38(07): 629-632.

Abstract

With the development of intraocular injection of anti-vascular endothelial growth factor (VEGF) drugs, early treatment of polypoidal choroidal vasculopathy (PCV) has more understanding and development.Once PCV combined with vitreous hemorrhage, treatment becomes much more difficult.The causes of vitreous hemorrhage in PCV, treatment of PCV with vitreous hemorrhage by different surgical methods, including simple vitrectomy, vitreous gas injection, intraoperative combined with vitrectomy and PDT, vitrectomy combined with CF6, retinal pigment epithelium transplantation and other vitrectomy, as well as common operation complications, postoperative recurrence and prognosis are summarized in this article.

Key words:

Polypoidal choroidal vasculopathy; Operation; Treatment

Contributor Information

Jiao Mingfei
Tianjin Medical University Eye Hospital, School of Optometry and Ophthalmology, TMU, Tianjin Medical University Eye Institute, Tianjin 300384, China
Li Xiaorong
Tianjin Medical University Eye Hospital, School of Optometry and Ophthalmology, TMU, Tianjin Medical University Eye Institute, Tianjin 300384, China
Hu Bojie
Tianjin Medical University Eye Hospital, School of Optometry and Ophthalmology, TMU, Tianjin Medical University Eye Institute, Tianjin 300384, China
(Read 23 times, 1 visits today)
Updated: July 27, 2020 — 1:18 am